Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence

Addiction Biology

Volumn 8, Issue 3, 2003, Pages 327-336

  Naidu, Pattipati S ^a   Singh, Amanpreet ^a   Joshi, Dipesh ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE; QUERCETIN;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; JUMPING; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL REFLEX;

ANALGESICS; ANALGESICS, OPIOID; ANIMALS; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; DRUG TOLERANCE; ENZYME INHIBITORS; FEMALE; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NOCICEPTORS; QUERCETIN;

EID: 0141593549     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210310001602248     Document Type: Article

References (29)

1. Bhargava HN. Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self administrative behavior. Pharmacol Rev 1994;46:293-324.
2. Dambisya YM, Lee TL. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 1996;117:914-18.
3. Reddy DS, Kulkarni SK. Chronic neurosteroid treatment prevents development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol 1997;337:19-25.
4. Ninan I, Kulkarni SK. Inhibition of morphine tolerance and dependence by Withania somnifera in mice. J Ethanopharmacol 1997;57:213-17.
5. Raghavendra V, Kulkarni SK. Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors. Brain Res 1999;834:178-81.
6. Vaccarino AL, Kastin AJ. Endogenous opiates 2000. Peptides 2001;22:2257-328.
7. Ceullar B, Fernandez AP, Lizasoani I et al. Up regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology 2000;148:66-73.
8. Powell KJ, Hosokawa A, Bell A et al. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 1999;127:631-44.
9. Miller AL. Antioxidant flavonoids: structure, function and clinical usage. Alt Med Rev 1996;1:103-11.
10. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli FS. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 1995;19:481-6.
11. De Whalley CV, Rankin SM, Hoult JR, Jessup W, Leke DS. Flavonoids inhibit the oxidative modification of low-density lipoproteins. Biochem Pharmacol 1990;39:1743-9.
12. Kaul TN, Middleton E Jr, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol 1985;15:71-9.
13. Bronner C, Landry Y. Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 1985;16:147-51.
14. Cappaso A, Piacente S, Pizza C, Sorrentino L. Flavonoids reduce morphine withdrawal in-vitro. J Pharm Pharmacol 1998;50:561-4.
15. Singh A, Naidu PS, Kulkarni S.K. Quercetin, a bioflavonoid reverses development of tolerance and dependence to morphine. Drug Dev Res 2002;57:167-72.
16. Majeed NH, Przewlocka B, Machelska H, Prezewlocka R. Inhibition of nitric oxide synthase attenuates the development of tolerance and dependence in mice. Neuropharmacology 1994;33:189-92.
17. Vaupel DB, Kimes AS, London ED. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology 1995;13:315-22.
18. Lue WM, Su MT, Lin WB, Tao PL. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices. Eur J Pharmacol 1999;383:129-35.
19. Mu MM, Chakravortty D, Sugiyama T, et al. The inhibitory action of quercitin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. J Endotoxin Res 2001;7:431-8.
20. El-Gawad A, Khalifa AE. Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. Pharmacol Res 2001;43:257-63.
21. Chen YC, Shen SC, Lee WR, Hou WC, Yang LL, Lee TJ. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J Cell Biochem 2001;82:537-48.
22. Ninan I, Kulkanri SK. Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice. Brain Res 2000;876:215-19.
23. Pataki I, Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. Eur J Pharmacol 1998;357:157-62.
24. Adams ML, Kalicki JM, Meyr ER, Cicero TJ. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor N-nitro-L-arginine methyl ester. Life Sci 1993;52:245-9.
25. Jhamandas JH, Harris KH, Petrov T, Jhamandas KH. Activation of nitric oxide synthesizing neurons during precipitated morphine withdrawal. Neuroreport 1996;7:2843-6.
26. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A. 1. Life Sci 2001;68:921-31.
27. Bhargava HN, Bian JT, Kumar S. Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. J Pharmacol Exp Ther 1997;281:707-12.
28. Prezewlocka B, Machelska H, Prezewlocka R. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci 1993;53:1-5.
29. Prezewlocka B, Machelska H, Prezewlocka R. Involvement of the nitric oxide pathway in nociceptive process in the central nervous system in rats. Regul Pept 1994;1:75-6.